Riskpilot← Back to searchSign inGet full accessBIOSYNERGY A/S
A/SActiveCVR 26664845Østerhovedvej 4Research and experimental development on natural sciences and engineering · NACE 7210Est. 20024 employees
Revenue 2024
DKK 2,5M
+23% vs 2023
EBITDA margin
60.1%
+40% vs 2023
Equity ratio
49.2%
Financial strength
Net profit 2024
DKK 765K
+81% vs 2023
| Revenue | DKK 2,5M | +23% |
| EBITDA | DKK 1,5M | +40% |
| Net profit | DKK 765K | +81% |
| Total assets | DKK 8,9M | -2% |
| Equity | DKK 4,4M | +21% |
| Employees | 4 | — |
Legal name
BIOSYNERGY A/S
CVR number
26664845
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
24. juni 2002
Share capital
DKK 500.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse i forening eller af direktøren alene så længe selskabet ejer eller driver en landbrugsejendom.
Company purpose
Selskabets formål er at eje og drive landbrug og væksthusgartneri samt enhver aktivitet, der efter direktionens skøn står i forbindelse hermed.
Address
Østerhovedvej 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 503 | 1.054 | 1.405 | 921 | 1.355 | 1.766 | 1.502 | 1.205 | 1.277 | 1.737 | 1.991 | 2.033 | 2.503 |
| Staff expenses | -270 | -487 | -619 | -413 | -546 | -497 | -517 | -523 | -332 | -517 | -983 | -958 | -998 |
| EBITDA | 234 | 567 | 786 | 508 | 809 | 1.269 | 985 | 681 | 945 | 1.220 | 1.007 | 1.075 | 1.505 |
| Depreciation & amort. | -123 | -139 | -202 | -202 | -225 | -401 | -473 | -407 | -563 | -588 | -604 | -412 | -415 |
| EBIT | 110 | 428 | 584 | 306 | 584 | 868 | 512 | 274 | 381 | 631 | 403 | 663 | 1.090 |
| Net financials | -21 | -4 | -12 | -331 | -309 | -369 | -402 | -102 | -79 | -138 | -114 | -120 | -105 |
| Profit before tax | 89 | 424 | 572 | -25 | 275 | 499 | 110 | 172 | 303 | 494 | 289 | 543 | 986 |
| Tax | 81 | 105 | 117 | -0 | 65 | 145 | 28 | 42 | 69 | 78 | 65 | 121 | 221 |
| Net profit | 8 | 319 | 455 | -25 | 210 | 354 | 82 | 130 | 234 | 416 | 224 | 422 | 765 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.745 | 3.843 | 5.860 | 7.263 | 7.622 | 8.029 | 7.925 | 8.092 | 7.666 | 9.124 | 9.839 | 9.128 | 8.904 |
| Equity | 987 | 1.210 | 1.569 | 1.543 | 1.753 | 2.107 | 2.190 | 2.319 | 2.553 | 2.969 | 3.193 | 3.616 | 4.381 |
| Long-term debt | 588 | 546 | 2.536 | 3.942 | 3.662 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.822 |
| Short-term debt | 1.032 | 1.945 | 1.562 | 1.584 | 1.949 | 2.309 | 2.054 | 2.501 | 2.343 | 2.330 | 3.440 | 2.952 | 2.364 |
| Total debt | 1.621 | 2.490 | 4.098 | 5.526 | 5.611 | 5.554 | 5.394 | 5.461 | 4.839 | 5.804 | 6.230 | 5.190 | 4.186 |
EBITDA margin
60.1%
This company
15.8%
Market median
+280% vs market
20122024
Equity ratio
49.2%
This company
38.2%
Market median
+29% vs market
20122024
Return on equity
17.5%
This company
18.4%
Market median
+5% vs market
20122024
Net profit margin
30.6%
This company
8.1%
Market median
+278% vs market
20122024
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20122024
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RJ | Audit | 2003 | — | — |
BT Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2009 | — | — | |
| Chairman | 2002 | — | — | |
| Board of Directors | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2002 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOSYNERGY A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Regnar Jørgensen Staugaard | Audit | 0 companies |
| Britta Tarp | Chief Executive Officer | 0 companies |
| Mette Dannesboe | Board of Directors | 0 companies |
| Bjørn Dannesboe | Chairman | 0 companies |
| Laurids Siig Christensen | Board of Directors | 0 companies |